HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robert D Goldman Selected Research

Therapeutics

1/2019Neutrophil-induced genomic instability impedes resolution of inflammation and wound healing.
2/2013Mechanical model of blebbing in nuclear lamin meshworks.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Robert D Goldman Research Topics

Disease

10Progeria (Hutchinson Gilford Syndrome)
06/2019 - 06/2004
6Premature Aging
01/2015 - 06/2004
5Neoplasms (Cancer)
01/2019 - 01/2012
4Laminopathies
03/2022 - 10/2005
4Rupture
01/2020 - 01/2019
4Blister (Bulla)
01/2018 - 12/2008
4Giant Axonal Neuropathy
01/2017 - 01/2013
2Inflammation (Inflammations)
01/2020 - 01/2019
2Breast Neoplasms (Breast Cancer)
06/2019 - 01/2019
2Nervous System Diseases (Neurological Disorders)
05/2013 - 01/2013
2Muscular Dystrophies (Muscular Dystrophy)
04/2008 - 10/2005
1Circulating Neoplastic Cells
11/2020
1Genomic Instability
01/2019
1Ureteral Obstruction
10/2018
1Fibrosis (Cirrhosis)
10/2018
1Inborn Genetic Diseases (Disease, Hereditary)
12/2016
1Alexander Disease (Alexander's Disease)
12/2016
1Rare Diseases (Rare Disease)
02/2016
1familial dilated cardiomyopathy
01/2016
1Starvation
11/2015
1Infections
07/2011
1Alzheimer Disease (Alzheimer's Disease)
02/2011
1Neoplasm Metastasis (Metastasis)
06/2010
1Virus Diseases (Viral Diseases)
04/2008
1Emery-Dreifuss Muscular Dystrophy (Scapuloperoneal Muscular Dystrophy)
10/2005
1Squamous Cell Carcinoma of Head and Neck
12/2002

Drug/Important Bio-Agent (IBA)

14LaminsIBA
03/2022 - 10/2005
12Lamin Type A (Lamin A)IBA
01/2018 - 06/2004
8Proteins (Proteins, Gene)FDA Link
01/2020 - 06/2004
6VimentinIBA
11/2020 - 06/2010
6ChromatinIBA
01/2020 - 10/2005
3Histones (Histone)IBA
01/2020 - 12/2008
3HeterochromatinIBA
06/2019 - 01/2018
3Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
02/2016 - 01/2013
3Lamin Type B (Lamin B)IBA
11/2015 - 01/2015
2CationsIBA
06/2019 - 01/2019
2RNA Polymerase II (RNA Polymerase B)IBA
01/2015 - 12/2008
1Carrier Proteins (Binding Protein)IBA
03/2022
1DNA (Deoxyribonucleic Acid)IBA
01/2020
11,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA
01/2019
1CateninsIBA
10/2018
1Keratins (Keratin)IBA
01/2017
1lamin CIBA
01/2016
1Small Interfering RNA (siRNA)IBA
03/2015
1Transcription Factors (Transcription Factor)IBA
01/2015
1RNA (Ribonucleic Acid)IBA
01/2015
1Farnesyltranstransferase (Farnesyltransferase)IBA
03/2013
1Viral DNAIBA
07/2011
1EpitopesIBA
07/2011
1Pharmaceutical PreparationsIBA
07/2011
1Caspase 6IBA
07/2011
1Insulysin (Insulin-Degrading Enzyme)IBA
02/2011
1Amyloid (Amyloid Fibrils)IBA
02/2011
1Peptides (Polypeptides)IBA
02/2011
1Insulin (Novolin)FDA Link
02/2011
1EuchromatinIBA
12/2008
1Proliferating Cell Nuclear Antigen (PCNA)IBA
04/2008
1Peptide Hydrolases (Proteases)FDA Link
12/2002

Therapy/Procedure

2Therapeutics
01/2019 - 02/2013